COVID vaccine weekly: why AstraZeneca vaccine received WHO backing even as South Africa paused rollout
As vaccine programmes gather pace worldwide, attention continues to focus on both viral mutations and the Oxford/AstraZeneca vaccine – sometimes simultaneously. South Africa has temporarily halted the vaccine’s rollout. This is because a preliminary study (yet to be released or reviewed by other scientists) suggests that the vaccine provides limited protection against mild to moderate cases of COVID-19 caused by the South African variant of the coronavirus. This may seem quite alarming. However, the study only involved young people, who tend to be less badly affected by COVID-19, and so it didn’t assess whether the vaccine protects against severe disease caused by the variant. Shabir Madhi, Professor of Vaccinology at Wits University in South Africa, who was involved in theContinue Reading